By Sujay Jadhav – In the complex, high-risk business of pharmaceutical research and development, sponsors face a challenge of picking target products with high therapeutic potential and acceptable safety profile. Then they must efficiently manage costs and timelines.
Read More
By Vish Srivastava – Specialty practices are engines of clinical insight. Every patient encounter generates information that cannot be found in clinical trials: real-world treatment patterns, longitudinal outcomes across diverse populations, and responses to therapies in patients who don’t qualify for the studies that brought those therapies to market.
By Thomas Kluz – The discovery of Yamanaka factors by Nobel laureate Shinya Yamanaka, which can reprogram adult cells into induced pluripotent stem cells, ignited serious scientific interest in whether aging might be partially reversible.
By Gil Bashe – When I discuss Healing the Sick Care System: Why People Matter with audiences, I expect nods of recognition acknowledging the mess and the hopelessness so many experience within today’s health system. I anticipate questions about what to do next and how to navigate a system that often feels stacked against both patients and professionals.
By Charles Castano – Clinical trial logistics is undergoing a profound digital transformation, moving from traditional manual processes toward integrated, technology-driven management systems that enhance efficiency, data integrity, and speed.
Clinical rotations sit at the center of health professional education, translating theory into real patient care; yet, the process of securing placements and preceptors has historically been fragmented, slow and uneven across regions and specialties.
By Jen Lamppa PhD – Clinical trials have a diversity problem. Despite years of effort, the participants in many studies still fail to reflect the true demographics of the populations they aim to serve. The consequences are profound: limited applicability of results, missed insights, and health inequities that persist across generations.
By Hilary Marston MD MPH & Kevin Bugin PhD – Breakthroughs in science and technology are advancing innovation in more areas of medicine, providing novel treatment options for patients. The scientific community has a deepening understanding of disease and human biology, and of the enormous potential afforded through new technologies.
By Wendy Morahan – Despite the critical nature of clinical trials in pharmaceutical research and development, trial stakeholders often struggle with managing scattered data across locations, systems and applications.